Pacific biosciences of california stock.
According to the issued ratings of 11 analysts in the last year, the consensus rating for Pacific Biosciences of California stock is Moderate Buy based on the current 3 hold ratings and 8 buy ratings for PACB. The average twelve-month price prediction for Pacific Biosciences of California is $11.80 with a high price target of $17.00 and a low ...
Stock analysis for Pacific Biosciences of California Inc (PACB:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Find out if Pacific Biosciences of California Inc (PACB:XNAS) stock is overpriced or undervalued based on Morningstar's evaluation. Assess the current comparison of market prices to the Fair Value ...Pacific Biosciences of California Stock Up 4.7 %. Pacific Biosciences of California stock opened at $8.88 on Friday. The company has a debt-to-equity ratio of 1.17, a quick ratio of 4.43 and a ...Nov 16, 2023 · Get the latest Pacific Biosciences of California Inc. (PACB) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. Oct 30, 2023 · Oct. 30, 2023, 04:07 PM. (RTTNews) - Pacific Biosciences of California, Inc. (PACB) released Loss for third quarter that decreased from the same period last year and beat the Street estimates. The ...
Pacific Biosciences of California, Inc. (PACB) Stock Price, Quote, News & Analysis PACB Pacific Biosciences of California, Inc. Stock Price & Overview 23.27K …Detailed statistics for Pacific Biosciences of California, Inc. (PACB) stock, including valuation metrics, financial numbers, share information and more. ... The stock price has decreased by -6.98% in the last 52 weeks. The beta is 1.72, so PACB's price volatility has been higher than the market average. Beta (1Y)As of February 15, 2023, 4:00 PM CST, Pacific Biosciences of California Inc’s stock price was $11.09. Pacific Biosciences of California Inc is up 7.88% from its previous closing price of $10.28. During the last market session, Pacific Biosciences of California Inc’s stock traded between $9.75 and $10.47.
PACB Stock Summary and Trading Ideas (Pacific Biosciences Of California | NASDAQ:PACB) · Trade Ideas for Best Option Strategies for PACB by Theoretical Edge and ...
Nov 6, 2023 · These 9 analysts have an average price target of $11.22 versus the current price of Pacific Biosciences at $7.2, implying upside. Below is a summary of how these 9 analysts rated Pacific ... KGI Securities started coverage on Pacific Biosciences of California and gave it an “outperform” rating in their report released on Wednesday June 7th. Morgan Stanley increased its price target for Pacific Biosciences of California from $12.00 to $13.00 and gave the stock an “equal weight” rating in their report on Thursday, August 3rd.Pacific Biosciences of California, Inc. Provides Revenue Guidance for the Fourth Quarter and the Fiscal Year Ended December 31, 2021 Jan 12 Price target …Pacific Biosciences of California, Inc. beats earnings expectations. Reported EPS is $-0.26, expectations were $-0.3. Operator: Good afternoon, everyone, and welcome to the PacBio Third Quarter ...
Nov 16, 2023 · Get the latest Pacific Biosciences of California Inc. (PACB) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.
Get the latest Pacific Biosciences of California, Inc. (PACB) stock news and headlines to help you in your trading and investing decisions. ... Pacific Biosciences of California, Inc. (NASDAQ:PACB ...
Pacific Biosciences of California Non-GAAP EPS of -$0.34 in-line, revenue of $35.5M beats by $0.34M SA News Wed, Aug. 03, 2022 As China looks to open up, here are the stocks with the most revenue ...Get the latest PACB stock quote, news, history and other vital information to help you with your stock trading and investing. See the performance outlook, earnings date, dividend …Pacific Biosciences Of California. stock was originally listed at a price of $16.44 in Oct 27, 2010. If you had invested in Pacific Biosciences Of California stock at $16.44, your return over the last 13 years would have been -47.99%, for an annualized return of -4.9% (not including any dividends or dividend reinvestments).Pacific Biosciences of California Inc. PACB (U.S.: Nasdaq) Pacific Biosciences of California Inc. View All companies. AT CLOSE 1:00 PM EST 11/24/23. $8.55 USD. In other news concerning Pacific Biosciences of California, insider Michele Farmer sold 5,165 shares of the company’s stock on May 18th at an average price of $12.59 per share, resulting in a total transaction value of $65,027.35. Following this sale, Farmer now holds 107,577 shares of PACB stock with an approximate value of $1,354,394.43.STOCK INFORMATION IRS Notification. Form 8937 Omniome. Stock Quote ... Pacific Biosciences of California, Inc. 1305 O’Brien Drive, Menlo Park, CA 94025
Also Known As Nanofluidics, Pacific Biosciences. Legal Name Pacific Biosciences of California, Inc. Stock Symbol NASDAQ:PACB. Company Type For Profit. Contact Email [email protected]. Phone Number 650-618-2699. PacBio designs, develops, and manufactures sequencing systems to resolve genetically complex problems. Its …Jan-26-23 08:52AM. Pacific Biosciences of California (NASDAQ:PACB) shareholder returns have been massive, earning 313% in 5 years. (Simply Wall St.) Jan-24-23 …Pacific Biosciences of California Inc. Watch NEW Set a price target alert Premarket Last Updated: Nov 28, 2023 8:00 a.m. EST Delayed quote $ 8.44 0.00 0.00% Before Hours Volume: 1 Advanced...Natural resources in California include waterways such as the San Joaquin Delta, the Pacific Ocean coastline, natural parks, plants and wildlife, and numerous habitats and ecosystems. Natural resources in California provide many economic an...Pacific Biosciences of California Inc does not have a meaningful P/E due to negative earnings over the last 12 trailing months. Pacific Biosciences of California Inc’s trailing 12-month revenue is $169.5 million with a -182.3% profit margin. Year-over-year quarterly sales growth most recently was 72.4%.Get the latest PACB stock quote, charts, news, and other financial information to help you make more informed trading and investment decisions. See the company's earnings, balance sheet, cash flow, and market cap for the second quarter of 2023.The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA. Pacific Biosciences of California Inc. 1305 O'Brien Drive. Menlo ...
The Relative Strength (RS) Rating for Pacific Biosciences of California stock jumped into a new percentile Wednesday, with a rise from 70 to 84.. X. When looking for the best stocks to buy and ...
Jan-26-23 08:52AM. Pacific Biosciences of California (NASDAQ:PACB) shareholder returns have been massive, earning 313% in 5 years. (Simply Wall St.) Jan-24-23 11:18PM. Pacific Biosciences of California, Inc. Announces Pricing of Upsized Public Offering of Common Stock.UBS Group upgraded shares of Pacific Biosciences of California (NASDAQ:PACB – Free Report) from a neutral rating to a buy rating in a research note issued to investors on Friday, Marketbeat.com reports. They currently have $10.00 price target on the biotechnology company’s stock, down from their previous price target of …Pacific Biosciences Of California. stock was originally listed at a price of $16.44 in Oct 27, 2010. If you had invested in Pacific Biosciences Of California stock …See the latest Pacific Biosciences of California Inc stock price (PACB:XNAS), related news, valuation, dividends and more to help you make your investing decisions.Get the latest PACB stock quote, charts, news, and other financial information to help you make more informed trading and investment decisions. See the company's earnings, …The Pacific Biosciences of California stock prediction for 2025 is currently $ 21.57, assuming that Pacific Biosciences of California shares will continue growing at the average yearly rate as they did in the last 10 years. This would represent a 157.52% increase in the PACB stock price.
The Pacific Biosciences of California stock prediction results are shown below and presented as a graph, table and text information. Pacific Biosciences of California stock forecasts are adjusted once a day based on the closing price of the previous trading day. The minimum target price for Pacific Biosciences of California …
Pacific Biosciences of California, Inc. (Nasdaq: PACB) ("PacBio") today announced that it has priced its previously announced underwritten public offering of 17,500,000 shares of its common stock ...
Jan 11, 2022 · The stock of Pacific Biosciences of California (PACB 2.27%), a company developing DNA sequencing machines, is losing ground after an investor update. Preliminary fourth-quarter sales figures ... Feb 10, 2021 · The notes will have a conversion price of $43.50 per share of the company's common stock, representing a 10% premium over Pacific Biosciences' share price as of the end of yesterday's trading session. finance.yahoo.com - October 6 at 3:53 PM. Pacific Biosciences of California, Inc. (NASDAQ:PACB) Insider Sells $162,529.08 in Stock. marketbeat.com - September 29 at 8:19 PM. Bernstein Initiates Coverage of Pacific Biosciences of California (PACB) with Outperform Recommendation. msn.com - September 28 at 11:07 …Get Pacific Biosciences of California (PACB) share price today, stock analysis, price valuation, performance, fundamentals, market cap, shareholding, ...Legal Name Pacific Biosciences of California, Inc. Stock Symbol NASDAQ:PACB. Company Type For Profit. Contact Email [email protected]. Phone Number 650-618-2699. PacBio designs, develops, and manufactures sequencing systems to resolve genetically complex problems. Its single molecule real-time (SMRT) sequencing technology enables ...Nov 28, 2023 · Christian O. Henry. Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template ... Pacific Biosciences of California Inc does not have a meaningful P/E due to negative earnings over the last 12 trailing months. Pacific Biosciences of California Inc’s trailing 12-month revenue is $169.5 million with a -182.3% profit margin. Year-over-year quarterly sales growth most recently was 72.4%.Legal Name Pacific Biosciences of California, Inc. Stock Symbol NASDAQ:PACB. Company Type For Profit. Contact Email [email protected]. Phone Number 650-618-2699. PacBio designs, develops, and manufactures sequencing systems to resolve genetically complex problems. Its single molecule real-time (SMRT) sequencing technology enables ...Pacific Biosciences of California Inc’s price is currently up 8.37% so far this month. During the month of March, Pacific Biosciences of California Inc’s stock price has reached a high of $10.00 and a low of $8.52. Over the last year, Pacific Biosciences of California Inc has hit prices as high as $14.20 and as low as $3.85.Nov 27, 2023 · The average twelve-month price prediction for Pacific Biosciences of California is $11.80 with a high price target of $17.00 and a low price target of $8.00. Learn more on PACB's analyst rating history. Do Wall Street analysts like Pacific Biosciences of California more than its competitors? Pacific Biosciences of California Stock Forecast and Price Target. Year-long price target forecasts from four prominent analysts have recently been released for Pacific Biosciences of California, with an average price target of $10.50. This potential gain of 24.41 percent from the previous closing price in November, 2023 is calculated on …The share float percentage for the stock currently stands at 98.68%. There are 96.98% institutions holding the Pacific Biosciences of California Inc stock share, with ARK Investment Management, LLC the top institutional holder. As of Sep 29, 2023, the company held 11.15% of the shares, roughly 29.82 million PACB shares worth $247.68 …
Nov 15, 2023 · Get Pacific Biosciences of California Inc (PACB.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments Nov 6, 2023 · These 9 analysts have an average price target of $11.22 versus the current price of Pacific Biosciences at $7.2, implying upside. Below is a summary of how these 9 analysts rated Pacific ... Pacific Biosciences of California (PACB) (Delayed Data from NSDQ) $8.55 USD +0.19 (2.27%) Updated Nov 24, 2023 01:00 PM ET After-Market: $8.72 +0.17 …Instagram:https://instagram. chiropractor cost no insurancesports ai predictioninstacart share pricebest colorado mortgage lenders A stock with a P/E ratio of 20, for example, is said to be trading at 20 times its trailing twelve months earnings. ... Pacific Biosciences of California rises after UBS upgrades on strong 'Revio ...The Pacific Biosciences of California stock prediction results are shown below and presented as a graph, table and text information. Pacific Biosciences of California stock forecasts are adjusted once a day based on the closing price of the previous trading day. The minimum target price for Pacific Biosciences of California … best canadian online tradingetf for nasdaq The Pacific Biosciences of California stock prediction results are shown below and presented as a graph, table and text information. Pacific Biosciences of California stock forecasts are adjusted once a day based on the closing price of the previous trading day. The minimum target price for Pacific Biosciences of California analysts is $. Today ... what is the best platform for trading options Pacific Biosciences of California, Inc. (PACB) NASDAQ: PACB · IEX Real-Time Price · USD. Add to Watchlist 8.55 +0.19 (2.27%) At close: Nov 24, 2023, 1:00 PM. 8.75 ... According to 10 stock analysts, the average 12-month stock price forecast for PACB stock stock is $11.8, which predicts an increase of 38.01%. The lowest target is …The stock of Pacific Biosciences of California (PACB 2.27%), a company developing DNA sequencing machines, is losing ground after an investor update. Preliminary fourth-quarter sales figures ...The current consensus among the 12 polled investment analysts is to buy stock in Pacific Biosciences of California Inc. PACB reported earnings per share of -$0.30 for the current quarter and $53.0 million in sales for the same period. However, it is important to note that the financial data provided is as of February 14 and may not be the …